Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hagin

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Immunology|July 16, 2020
Novel NCF2 Mutation Causing Chronic Granulomatous DiseaseIdit Lachover Roth, Pazit Salamon, Tal Freund, et al.
Eye (London, England)|October 26, 2025
Metagenomic next-generation sequencing: a game-changer in the diagnosis of unique intraocular infectionsZohar Habot-Wilner, Michael Ostrovsky, Dinah Zur, et al.
Eye (London, England)|March 28, 2026
Response to: 'Comment on 'Metagenomic next-generation sequencing: a game changer in the diagnosis of unique intraocular infections''Zohar Habot-Wilner, Michael Ostrovsky, Dinah Zur, et al.
Open Forum Infectious Diseases|August 4, 2023
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort StudyLuba Tau, David Hagin, Tal Freund, et al.
Rheumatology (Oxford, England)|February 18, 2022
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medicationsMerav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, et al.
Transplantation and Cellular Therapy|February 19, 2022
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort StudyRon Ram, Tal Freund, Tami Halperin, et al.
Blood|March 1, 2013
A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsAssaf Lask, Eran Ophir, Noga Or-Geva, et al.
Frontiers in Immunology|November 17, 2018
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) SyndromeEleonora Gambineri, Sara Ciullini Mannurita, David Hagin, et al.
Experimental Dermatology|January 14, 2026
Defective Function of Inhibitor of κB Kinase Subunit Beta Associated With Multiple Immune-Mediated DisordersKiril Malovitski, Noy Keller Rosenthal, Lubna Khair, et al.
Open Forum Infectious Diseases|March 31, 2022
SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical CenterLuba Tau, Dan Turner, Amos Adler, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Immunology|July 16, 2020
Novel NCF2 Mutation Causing Chronic Granulomatous DiseaseIdit Lachover Roth, Pazit Salamon, Tal Freund, et al.
Eye (London, England)|October 26, 2025
Metagenomic next-generation sequencing: a game-changer in the diagnosis of unique intraocular infectionsZohar Habot-Wilner, Michael Ostrovsky, Dinah Zur, et al.
Eye (London, England)|March 28, 2026
Response to: 'Comment on 'Metagenomic next-generation sequencing: a game changer in the diagnosis of unique intraocular infections''Zohar Habot-Wilner, Michael Ostrovsky, Dinah Zur, et al.
Open Forum Infectious Diseases|August 4, 2023
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort StudyLuba Tau, David Hagin, Tal Freund, et al.
Rheumatology (Oxford, England)|February 18, 2022
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medicationsMerav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, et al.
Transplantation and Cellular Therapy|February 19, 2022
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort StudyRon Ram, Tal Freund, Tami Halperin, et al.
Blood|March 1, 2013
A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsAssaf Lask, Eran Ophir, Noga Or-Geva, et al.
Frontiers in Immunology|November 17, 2018
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) SyndromeEleonora Gambineri, Sara Ciullini Mannurita, David Hagin, et al.
Experimental Dermatology|January 14, 2026
Defective Function of Inhibitor of κB Kinase Subunit Beta Associated With Multiple Immune-Mediated DisordersKiril Malovitski, Noy Keller Rosenthal, Lubna Khair, et al.
Open Forum Infectious Diseases|March 31, 2022
SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical CenterLuba Tau, Dan Turner, Amos Adler, et al.
Pageof 10